Table 2.

Concentrations of total and HMWA in patients with and without the metabolic syndrome

	Total adiponectin (μg/ml)	P	HMWA (μg/ml)	P
ATP criteria
All (n = 269)
Metabolic syndrome (n = 77)	7.26 [3.57]	0.006	4.10 [3.07]	0.007
No metabolic syndrome (n = 192)	8.91 [4.84]		5.05 [4.03]
Men (n = 101)
Metabolic syndrome (n = 30)	6.44 [2.94]	0.183	3.25 [2.13]	0.245
No metabolic syndrome (n = 71)	7.32 [2.65]		3.50 [3.00]
Women (n = 168)
Metabolic syndrome (n = 47)	8.68 [4.58]	0.024	4.60 [5.00]	0.037
No metabolic syndrome (n = 121)	10.06 [4.91]		5.80 [4.20]
IDF criteria
All (n = 269)
Metabolic syndrome (n = 102)	7.27 [3.39]	< 0.001	3.95 [2.48]	< 0.001
No metabolic syndrome (n = 167)	9.11 [4.98]		5.40 [4.40]
Men (n = 101)
Metabolic syndrome (n = 45)	6.68 [2.79]	0.123	3.20 [1.80]	0.114
No metabolic syndrome (n = 56)	7.52 [2.93]		3.55 [3.48]
Women (n = 168)
Metabolic syndrome (n = 57)	8.68 [4.33]	0.002	4.60 [4.55]	0.007
No metabolic syndrome (n = 111)	10.48 [4.71]		6.20 [4.40]

Values are medians [IQR]. Number of subjects in each group is indicated in parentheses.